Search Result

Results for "

glucosidase

" in MedChemExpress (MCE) Product Catalog:

By Targets:	AMPK (1) Amylases (37) Angiotensin-converting Enzyme (ACE) (1) Antibiotic (4) Apoptosis (11) Aryl Hydrocarbon Receptor (4) Bacterial (8) Bcl-2 Family (2) Biochemical Assay Reagents (8) Carbonic Anhydrase (1) Cholinesterase (ChE) (7) COX (2) Dengue Virus (3) Dipeptidyl Peptidase (6) Endogenous Metabolite (21) Enterovirus (1) Estrogen Receptor/ERR (3) Flavivirus (4) Fluorescent Dye (2) Fungal (4) Glucokinase (2) GLUT (2) Glutaminase (1) Glutathione Peroxidase (2) Glycosidase (294) HBV (2) HCV (2) HDAC (1) HIV (4) HIV Protease (1) HMG-CoA Reductase (HMGCR) (2) Influenza Virus (2) Isotope-Labeled Compounds (5) Lipoxygenase (2) Monoamine Oxidase (3) NF-κB (1) NOD-like Receptor (NLR) (1) P-glycoprotein (1) Parasite (6) Phosphatase (7) Phosphodiesterase (PDE) (2) Phospholipase (1) PI3K (3) PKC (1) Potassium Channel (1) PPAR (5) Reactive Oxygen Species (ROS) (5) Reference Standards (22) SARS-CoV (1) TGF-β Receptor (1) Tyrosinase (4) α-synuclein (2)
By Research Areas:	Cancer (42) Cardiovascular Disease (10) Endocrinology (7) Infection (46) Inflammation/Immunology (35) Metabolic Disease (230) Neurological Disease (25)
Click Chemistry:	Azide (1)

342

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

142

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Click Chemistry

*α-Glucosidase, Yeast* α-D-glucosidase, Yeast	Glycosidase	Metabolic Disease
α-Glucosidase, Yeast (α-D-Glucosidase, Yeast), a carbohydrate hydrolyzing enzyme, catalyzes the liberation of α-glucose from the non-reducing end of the substrate. α-Glucosidase can facilitate the absorption of glucose by the small intestine. Inhibition of α-Glucosidase is an effective management of non-insulin-dependent diabetes mellitus (NIDDM) .

*β-Glucosidase, almond* 1 Publications Verification	Glycosidase	Others
β-Glucosidase, almond is the rate-limiting enzyme in cellulose degradation. β-Glucosidase is a major group among glycoside hydrolases. β-Glucosidase is involved in the degradation of cellulose in soils and has potential for monitoring soil quality .

*α-Glucosidase-IN-32*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-32 (compound f26) is a reversible, noncompetitive and orally active α-glucosidase inhibitor with an IC₅₀ value of 3.07 μM. α-Glucosidase-IN-32 complex with α-glucosidase through hydrogen bonds and hydrophobic interactions, led to changes in the conformation and secondary strictures of α-glucosidase and further the inhibition of the enzymatic activity. α-Glucosidase-IN-32 can be used for diabetic disease research .

*α-Glucosidase-IN-23*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-23 is an orally active *α-Glucosidase* inhibitor. α-Glucosidase-IN-23 decreases blood glucose by a-glucosidase inhibition with an IC₅₀ value of 4.48 μM. α-Glucosidase-IN-23 can be used for the research of diabetes .

*α-Glucosidase-IN-91*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-91 (Compound 15j) is a competitive and potent inhibitor for *α-Glucosidase* (IC₅₀ = 6.6 μM). α-Glucosidase-IN-91 has a potent binding affinity towards α-Glucosidase. α-Glucosidase-IN-91 exhibits high stability, interacting and inhibiting α-Glucosidase selectively. α-Glucosidase-IN-91 can be studied in research for type 2 diabetes and blood glucose control .

*α-Glucosidase-IN-11*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-11 is a highly permeable competitive *α-glucosidase* inhibitor with the IC₅₀ value of 0.56 μM. α-Glucosidase-IN-11 binds to Trp residues in α-glucosidase and regulates protein folding. α-Glucosidase-IN-11 can be used to regulate blood glucose levels .

*α-Glucosidase-IN-90*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-90 (Compound 7b) is an *α-Glucosidase* inhibitor (IC₅₀: 14.48 nM). α-Glucosidase-IN-90 binds to HIS:280 and ASN:415 residues of α-glucosidase via hydrogen bonds, inhibiting the activity of the enzyme. α-Glucosidase-IN-90 can be used in the study of diabetes .

*α-Glucosidase-IN-47*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-47 (compound 8H) is a non-competitive α-glucosidase (α-glucosidase) inhibitor with IC₅₀ value is 38.2 μM and K_i value is 38.2 μM. α-Glucosidase-IN-47 can be used in diabetes research. .

*α-Glucosidase-IN-63*	Glycosidase Carbonic Anhydrase	Endocrinology
α-Glucosidase-IN-63 (Compound 4d) is an inhibitor of *α-Glucosidase* (IC₅₀=0.44 μM). α-Glucosidase-IN-63 inhibits hCA II with an activity of K_i= 7.0 nM. α-Glucosidase-IN-63 is orally effective. .

*α-Glucosidase-IN-28*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-28 (Compound 18) is a *α-Glucosidase* inhibitor (IC₅₀: 0.62 μM, K_i: 3.93 μM). α-Glucosidase-IN-28 binds to α-glucosidase at the original binding site (OBS), and forms multiple hydrophobic interactions with nearby amino acids. α-Glucosidase-IN-28 can be used for research of diabetes and related diseases .

*α-Glucosidase-IN-51*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-51 (compound 9) is an inhibitor of *α-Glucosidase* .

*α-Glucosidase-IN-50*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-50 (compound 8) is an inhibitor of *α-Glucosidase* .

*α-Glucosidase-IN-2*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-2 (compound 5d) is a potent *α-Glucosidase* inhibitor with an IC₅₀ of 9.48 µM. α-Glucosidase-IN-2 is an antidiabetic agent .

*α-Glucosidase-IN-24*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-24 (Compound 13) is an *α-Glucosidase* inhibitor with an IC₅₀ of 451 μM. α-Glucosidase-IN-24 can be isolated from Swertia kouitchensis .

*α-Glucosidase-IN-39*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-39 is a potent inhibitor of *α-glucosidase* enzyme with an IC₅₀** of 869.06 ppm. α-Glucosidase-IN-39 can used in study antidiabetic .

*α-Glucosidase-IN-73*	Glycosidase	Metabolic Disease Inflammation/Immunology
α-Glucosidase-IN-73 (compound 16b) is an *α-Glucosidase* inhibitor with IC₅₀ of 0.158 μM. α-Glucosidase-IN-73 can activate PPAR γ. α-Glucosidase-IN-73 can be used in anti-diabetic and anti-inflammatory studies .

*α-Glucosidase-IN-44*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-44 (compound IT4) is an inhibitor of *α-glucosidase* with IC₅₀ value of 2.35 μM. α-Glucosidase-IN-44 has an oral activity. α-Glucosidase-IN-44 suppresses fasting blood glucose levels in diabetic mice .

*α-Glucosidase-IN-36*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-36 (compound 5g) is a potent *α-glucosidase* inhibitor, with an IC₅₀ of 6.69 ± 0.18 μM, K_i and K_is of 1.65 μM and 4.54 μM, respectively. α-Glucosidase-IN-36 may inhibit α-glucosidase activity by binding with its active site as well as changing the secondary structure of α-glucosidase. α-Glucosidase-IN-36 can be used for type 2 diabetes mellitus (T2DM) research .

*α-Glucosidase-IN-35*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-35 (compound 1) is a kind of chromene. α-Glucosidase-IN-35 can be isolated from the aqueous extract of the aerial parts of Brickellia cavanillesii. α-Glucosidase-IN-35 is a potent inhibitor of *α-glucosidase* with an IC₅₀ value of 0.169 mg/mL .

*α-Glucosidase-IN-46*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-46 is a potent *α-glucosidase* inhibitor with an IC₅₀ of 26.0 μM. α-Glucosidase-IN-46 can be used for the research of type 2 diabetes .

*α-Glucosidase-IN-6*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-6 (compound 18) is a competitive *α-glucosidase* inhibitor with an IC₅₀ of 5.69 µM. α-Glucosidase-IN-6 has anti-diabetic potential .

*α-Glucosidase-IN-81*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-81 (Compound 5) is a potent *α-Glucosidase* inhibitor with an IC₅₀ value of 5.30 μM. α-Glucosidase-IN-81 is promising for research of diabetes .

*α-Glucosidase-IN-52*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-52 (Compound 3h) is an *α-glucosidase* inhibitor with an IC₅₀ of 2.8 μM. α-Glucosidase-IN-52 can be used for diabetes research .

*α-Glucosidase-IN-67*	Amylases Glycosidase	Metabolic Disease
α-Glucosidase-IN-67 (compound 5k) is a potent *α-Glucosidase* inhibitor with IC₅₀ values of 0.31, 4.51 µM for alpha-glucosidase and alpha-amylase, respectively. α-Glucosidase-IN-67 has the potential for the research of type-2 diabetes .

*α-Glucosidase-IN-41*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-41 (compound 5o) is a potent *α-glucosidase* inhibitor. α-Glucosidase-IN-41 can arise the changed secondary structure of α-Glu to hinder enzyme catalytic activity. α-Glucosidase-IN-41 can be used for diabetes mellitus research .

*α-Glucosidase-IN-42*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-42 (Compound 26) is a 9-O-berberrubine carboxylate derivative. α-Glucosidase-IN-42 has potent α-glucosidase inhibitory activities with an IC₅₀ value in the range of 1.61 μM. α-Glucosidase-IN-42 can be used for the research of antidiabetic .

*α-Glucosidase-IN-5*	Glutaminase	Metabolic Disease
α-Glucosidase-IN-5 (compound 8) is a potent *α-glucosidase* inhibitor with an IC₅₀ of 57.9 µM. α-Glucosidase-IN-5 has the potential for the research of diabetes mellitus .

*α-Glucosidase-IN-18*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-18 (7B) is an orally active *α-glucosidase* inhibitor with an IC₅₀ value of 3.96 μM. α-Glucosidase-IN-18 has antidiabetic activity .

*α-Glucosidase-IN-9*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-9 (compound 7) is a potent *α-glucosidase* inhibitor, with an IC₅₀ of 55.6 μM. α-Glucosidase-IN-9 can be used for type II diabetes research .

*α-Glucosidase-IN-15*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-15 (Compound 14B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 3.34 μM. α-Glucosidase-IN-15 shows antidiabetic activity .

*α-Glucosidase-IN-93*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-93 (Compound 5b) is a potent *α-glucosidase* inhibitor with an IC₅₀ value of 49.18 nM. α-Glucosidase-IN-93 is promising for research of type 2 diabetes .

*α-Glucosidase-IN-10*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-10 (compound 13) is a potent *α-glucosidase* inhibitor, with an IC₅₀ of 92.7 μM. α-Glucosidase-IN-10 can be used for type II diabetes research .

*α-Glucosidase-IN-94*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-94 (Compound 6e) is a potent *α-glucosidase* inhibitor with an IC₅₀ value of 0.1412 mM. α-Glucosidase-IN-94 is promising for research of type 2 diabetes .

*α-Glucosidase-IN-17*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-17 (Compound 12B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 3.79 μM. α-Glucosidase-IN-17 shows antidiabetic activity .

*α-Glucosidase-IN-86*	Glycosidase	Metabolic Disease Inflammation/Immunology
α-Glucosidase-IN-86 (Compound A4) is an orally active *α-glucosidase* inhibitor with an IC₅₀ of 2.72 μM. α-Glucosidase-IN-86 has high safety in mice. α-Glucosidase-IN-86 can reduce fasting blood glucose levels, improve glucose tolerance, regulate blood lipids, and has antioxidant effects in diabetic mice. α-Glucosidase-IN-86 can be used for the research of diabetes .

*α-Glucosidase-IN-19*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-19 (Compound 6B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 3.63 μM. α-Glucosidase-IN-19 shows anti-diabetic activity .

*α-Glucosidase-IN-54*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-54 (compound 2) is a *α-glucosidase* inhibitor with the IC₅₀ of 0.011 mM, and can be isolated form Syzygium jambos (L.). α-Glucosidase-IN-54 can be used for study of diabetes .

*α-Glucosidase-IN-45*	Glycosidase	Cancer
α-Glucosidase-IN-45 (compound 11E) is an inhibitor of *α-glucosidase. α-Glucosidase*-IN-45 is a novel indol-fused pyrano[2,3-D]pyrimidine compound .

*α-Glucosidase-IN-75*	Glycosidase	Cardiovascular Disease Metabolic Disease
α-Glucosidase-IN-75 (compound 13) is an *α-glucosidase* inhibitor with an IC₅₀ of 3.81 μM. α-Glucosidase-IN-75 can be used for the study of high glucose-induced cardiovascular diseases .

*α-Glucosidase-IN-65*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-65 (compound 5) is a Schiff base derivative of 3,4-dihydroxyphenylacetic acid. α-Glucosidase-IN-65 is a potent *α-glucosidase* inhibitor, with an IC₅₀ of 12.84 μM .

*α-Glucosidase-IN-85*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-85 (Compound 8D1) is the inhibitor for *α-Glucosidase* with an IC₅₀ of 5.43 μM. α-Glucosidase-IN-85 can be used in research of type 2 diabetes .

*α-Glucosidase-IN-21*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-21 (Compound 2B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 2.62 μM. α-Glucosidase-IN-21 shows anti-diabetic activity .

*α-Glucosidase-IN-20*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-20 (Compound 3B) is a potent, orally active *α-glucosidase* inhibitor with an IC₅₀ of 3.01 μM. α-Glucosidase-IN-20 shows anti-diabetic activity .

*α-Glucosidase-IN-95*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-95 (Compound 21c) is a competitive *α-Glucosidase* inhibitor with an IC₅₀ of 0.44  μM. α-Glucosidase-IN-95 has a significant inhibitory potency without cytotoxicity to normal cells. α-Glucosidase-IN-95 can be used for metabolic disorders like diabetes mellitus research .

*α-Glucosidase-IN-83*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-83 (compound I-1) is a potent inhibitor of *α-Glucosidase, with the IC₅₀* of 1.49 μg/mL. α-Glucosidase-IN-83 shows reduction in blood glucose levels in vivo .

*α-Glucosidase-IN-56*	Glycosidase	Metabolic Disease
α-Glucosidase-IN-56 (compound 1) is an orally active, potent *α‐glucosidase* inhibitor with an IC₅₀ value of 45.86 μM. α-Glucosidase-IN-56 has potent anti-glycation activities .

Cat. No.	Product Name	Type

HY-W357142

3-Acetylumbelliferyl β-D-Glucopyranoside	Chromogenic Substrates Fluorescent Dyes/Probes
3-Acetylumbelliferyl β-D-Glucopyranoside is a fluorogenic substrate for β-glucosidase and can be used as a positive control substrates for β-D-glucosidase .

Cat. No.	Product Name	Type

HY-W039859

2-Chloro-4-nitrophenyl β-D-glucopyranoside, 98%	Carbohydrates
2-Chloro-4-nitrophenyl β-D-glucopyranoside, 98% is a substrate for β-glucosidase, used as a bacterial growth medium.

HY-W005598

2-Hydroxyquinoline	Biochemical Assay Reagents
2-Hydroxyquinoline is an inhibitor of *α-glucosidase* and α-amylase with IC₅₀ values of 64.4 µg/mL and 130.5 µg/mL, respectively. 2-Hydroxyquinoline can be used in the study of diabetes .

HY-129217

Naringinase 1 Publications Verification	Biochemical Assay Reagents
Naringinase, a hydrolytic enzymatic complex, possesses the activity of both α-L-rhamnosidase and β-D-glucosidase. Naringinase has wide occurrence in nature. Naringinase can be used in the biotransformation of steroids, antibiotics, and mainly on glycosides hydrolysis .

HY-15927

4-Nitrophenyl β-D-glucopyranoside

1 Publications Verification

Enzyme Substrates

4-Nitrophenyl β-D-glucopyranoside is a chromogenic substrate for β-glucosidase. 4-Nitrophenyl β-D-glucopyranoside is converted to a colored product, p-nitrophenol that is easily detected spectrophotometrically at 405 nm when used in a β-glycosidase assay. 4-Nitrophenyl β-D-glucopyranoside is hydrolysed through intramolecular nucleophilic catalysis by the phosphate group in the 2-position. 4-Nitrophenyl β-D-glucopyranoside is promising for research of postmenopausal osteoporosis .

HY-E70183

Lysosomal α-Glucosidase EC:3.2.1.20; GAA	Enzyme Substrates
Lysosomal α-Glucosidase (EC:3.2.1.20) is a γ-amylase with specificity for glycogen and several natural and synthetic oligoglucosides .

HY-W011410

4-Nitrophenyl β-D-mannopyranoside p-Nitrophenyl β-D-Mannopyranoside	Carbohydrates
4-Nitrophenyl β-D-mannopyranoside is a useful substrate for β-D-mannopyranosidase. 4-Nitrophenyl β-D-mannopyranoside is also a substrate for *GH1-glucosidase* (EaBgl1A) and α-L-rhamnosidase** .

HY-W826489

D-Glucopyranose, 98% α-Sophorose, 98%	Carbohydrates
D-Glucopyranose, 98% serves as a substrate for various glycosidase enzymes, including α-glucosidase, and is also used in glycobiology research.

HY-W288349

8-Quinolinyl β-D-glucopyranoside	Carbohydrates
8-Quinolinyl β-D-glucopyranoside is an 8-hydroxyquinoline glucoconjugate that can be cleaved in vitro by β-glucosidase .

HY-136868

Resorufin-β-D-glucopyranoside, 98% 3-Phenoxazone 7-(β-D-glucopyranoside),98%	Carbohydrates
Resorufin-β-D-glucopyranoside, 98% (3-Phenoxazone 7-(β-D-glucopyranoside), 98%) can be used to detect and quantify β-glucosidase activity in various biological samples.

HY-W292085

6-Chloro-1H-indol-3-yl β-D-glucopyranoside	Carbohydrates
6-Chloro-1H-indol-3-yl β-D-glucopyranoside can be used to detect chromogenic medium for studying yeast with β-glucosidase activity .

Cat. No.	Product Name	Target	Research Area

HY-138815

(S)-N-(1H-Indole-3-acetyl)tryptophan	Glycosidase	Metabolic Disease
(S)-N-(1H-Indole-3-acetyl)tryptophan (compound 4a) is a Tryptophan derivative that weakly inhibits *β-D-glucosidase* .

HY-101399R

γ-Glu-Phe (Standard) γ-Glutamylphenylalanine (Standard)	Reference Standards Endogenous Metabolite	Others
Ceftezole (sodium) (Standard) is the analytical standard of Ceftezole (sodium). This product is intended for research and analytical applications. Ceftezole sodium (CTZ sodium) is a broad-spectrum cephem antibiotic against many species of gram-positive and gram-negative bacteria. Ceftezole sodium (CTZ sodium) is an alpha-glucosidase inhibitor with in vivo anti-diabetic activity .

HY-P5201S1

VTSEGAGLQLQK-13C6,15N2 TFA	Isotope-Labeled Compounds	Others
VTSEGAGLQLQK- ¹³C₆, ¹⁵N₂ (TFA) is the ¹³C- and ¹⁵N-labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA), which can be used to bind anti-drug antibodies in plasma and quantitatively analyze the therapeutic effect .

Cat. No.	Product Name	Target	Research Area

HY-P99803

Clervonafusp alfa VAL-1221	Glycosidase	Others
Clervonafusp alfa (VAL-1221) is a fusion protein targeting both cytosolic and lysosomal glycogen. Clervonafusp alfa is comprised of the Fab portion of a cell-penetrating antibody and recombinant human acid alpha glucosidase (rhGAA), the former utilizing the nucleoside transporter ENT-2 to gain access to the cytosol, and the latter enters lysosomes via mannose-6-phosphate receptors (M6PRs). Clervonafusp alfa can be used for late-onset Pompe disease research .

Species:	Human (2) Mouse (1)
Tag:	His (4) Tag Free (2) Strep (1) GST (1) Flag (1)
Source:	HEK293 (2) E. coli (5)

Cat. No.	Compare	Product Name	Species	Source

HY-P71650

	*Cytosolic beta-Glucosidase/GBA3 Protein, Human (GST)* CBG; CBGL1; Cytosolic beta glucosidase ; Cytosolic beta glucosidase like protein 1; Cytosolic beta-glucosidase; glucosidase beta acid 3; Klotho related protein ; KLRP	Human	E. coli
	Cytosolic β-glucosidase/GBA3 is a multifunctional neutral cytosolic β-glucosidase that displays broad substrate specificity, suggesting a possible involvement in glycosylceramide catabolism. Although it exhibits significant glucosylceramidase activity in vitro, its in vivo relevance is unclear. Cytosolic beta-Glucosidase/GBA3 Protein, Human (GST) is the recombinant human-derived Cytosolic beta-Glucosidase/GBA3 protein, expressed by E. coli , with N-GST labeled tag.

HY-P703073

	GBA/Glucosylceramidase Protein, Mouse (HEK293, His) Acid beta-glucosidase; Beta-glucocerebrosidase; SGTase; Cholesteryl-beta-glucosidase	Mouse	HEK293
	GBA/glucosylceramidase protein catalyzes the hydrolysis of glucosylceramide/GlcCers into free ceramide and glucose within lysosomes. It plays a key role in lipid degradation and cell membrane turnover. GBA/Glucosylceramidase Protein, Mouse (HEK293, His) is the recombinant mouse-derived GBA/Glucosylceramidase protein, expressed by HEK293 , with N-10*His labeled tag.

HY-P703794

	GBA/glucocerebrosidase Protein, Human (HEK293, His) Acid beta-glucosidase; Beta-glucocerebrosidase; SGTase; Cholesteryl-beta-glucosidase	Human	HEK293
	GBA/glucocerebrosidase Protein, Human (HEK293, His) is the recombinant human-derived GBA/glucocerebrosidase protein, expressed by HEK293, with C-His tag.

HY-P702159

	pulB Protein, Pullulanibacillus naganoensis pulB; Alpha-dextrin endo-1; 6-alpha-glucosidase; Pullulan 6-glucanohydrolase	Others	E. coli
	PulB is a protein belonging to the glycosyl hydrolase 13 family. The glycosyl hydrolase 13 family contains enzymes involved in the breakdown of complex carbohydrates by catalyzing the hydrolysis of glycosidic bonds. pulB Protein, Pullulanibacillus naganoensis is the recombinant pulB protein, expressed by E. coli , with tag free.

HY-P702160

	pulB Protein, Pullulanibacillus naganoensis (FLAG, His) pulB; Alpha-dextrin endo-1; 6-alpha-glucosidase; Pullulan 6-glucanohydrolase	Others	E. coli
	PulB is a protein belonging to the glycosyl hydrolase 13 family. The glycosyl hydrolase 13 family contains enzymes involved in the breakdown of complex carbohydrates by catalyzing the hydrolysis of glycosidic bonds. pulB Protein, Pullulanibacillus naganoensis (FLAG, His) is the recombinant pulB protein, expressed by E. coli , with N-6*His, N-Flag labeled tag.

HY-P703445

	susB Protein, Bacteroides thetaiotaomicron Glucan 1,4-alpha-glucosidase SusB; Alpha-glucosidase SusB; Glucoamylase SusB; Starch-utilization system protein B; susB; Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50); Glycosidase; Hydrolase; 3.2.1.3	Others	E. coli
	susB Protein, Bacteroides thetaiotaomicron is the recombinant susB, expressed by E. coli , with tag Free labeled tag. ,

HY-P703446

	susB Protein, Bacteroides thetaiotaomicron (His, Strep) Glucan 1,4-alpha-glucosidase SusB; Alpha-glucosidase SusB; Glucoamylase SusB; Starch-utilization system protein B; susB; Bacteroides thetaiotaomicron (strain ATCC 29148 / DSM 2079 / JCM 5827 / CCUG 10774 / NCTC 10582 / VPI-5482 / E50); Glycosidase; Hydrolase; 3.2.1.3	Others	E. coli
	susB Protein, Bacteroides thetaiotaomicron (His, Strep) is the recombinant susB, expressed by E. coli , with Strep, His labeled tag. ,

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-P5201S

VTSEGAGLQLQK-13C6,15N2
VTSEGAGLQLQK- ¹³C₆, ¹⁵N₂ is the ¹³C and ¹⁵N labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA). VTSEGAGLQLQK can be used to bind anti-drug antibodies (ADA) in plasma and quantitatively analyze the therapeutic effect .

HY-P5201S1

VTSEGAGLQLQK-13C6,15N2 TFA
VTSEGAGLQLQK- ¹³C₆, ¹⁵N₂ (TFA) is the ¹³C- and ¹⁵N-labeled VTSEGAGLQLQK. VTSEGAGLQLQK is an amino acid sequence in the C-terminal region of recombinant human alpha-acid glucosidase (rhGAA), which can be used to bind anti-drug antibodies in plasma and quantitatively analyze the therapeutic effect .

HY-B0089S

Acarbose-d4
Acarbose-d₄ (BAY g 5421-d₄) is deuterium labeled Acarbose. Acarbose (BAY g 5421), antihyperglycemic agent, is an orally active *alpha-glucosidase* inhibitor (IC₅₀=11 nM). Acarbose can potentiate the hypoglycemic effects of sulfonylureas or insulin .

HY-N0464S

Quinic acid-13C3
Quinic acid- ¹³C₃ is the ¹³C-labeled D-(-)-Quinic acid. D-(-)-Quinic acid scavenges hydrogen peroxide (IC₅₀=87.11 μg/mL) and exhibits antioxidant activity. D-(-)-Quinic acid is the inhibitor for MAO and *α-Glucosidase* (IC₅₀ =93.75 μg/mL). D-(-)-Quinic acid is orally active .

HY-138815S

(S)-N-(1H-Indole-3-acetyl)tryptophan-d4
(S)-N-(1H-Indole-3-acetyl)tryptophan-d₄ is deuterium labeled (S)-N-(1H-Indole-3-acetyl)tryptophan. (S)-N-(1H-Indole-3-acetyl)tryptophan (compound 4a) is a Tryptophan derivative that weakly inhibits *β-D-glucosidase* .

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P80405

	Glucosidase 2 subunit beta Antibody (YA409)	WB, IHC-P, ICC/IF	Human
	Glucosidase 2 subunit beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa., targeting to Glucosidase 2 subunit beta. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.

HY-P86886

	GANAB Antibody (YA6579) Alpha glucosidase II alpha subunit antibody; Alpha-glucosidase 2 antibody; G2AN antibody; GANAB antibody; GANAB_HUMAN antibody; Glu II antibody; glucosidase alpha neutral AB antibody; glucosidase II alpha antibody; glucosidase II subunit alpha antibody; GluII antibody; Alpha glucosidase II alpha subunit antibody; Alpha-glucosidase 2 antibody; G2AN antibody; GANAB antibody; GANAB_HUMAN antibody; Glu II antibody; glucosidase alpha neutral AB antibody; glucosidase II alpha antibody; glucosidase II subunit alpha antibody; GluII antibody; KIAA0088 antibody; Neutral alpha glucosidase AB antibody; Neutral alpha glucosidase AB precursor antibody; Neutral alpha-glucosidase AB antibody	WB, IHC-P, IF-Tissue, IP	Human, Mouse, Rat

HY-P83127

	GAA Antibody (YA2872) Acid maltase; GAA; glucosidase alpha acid; LYAG	WB	Human, Mouse, Rat
	GAA Antibody (YA2872) is a non-conjugated IgG antibody, targeting GAA, with a predicted molecular weight of 105 kDa (observed band size: 120,100,75 kDa). GAA Antibody (YA2872) can be used for WB experiment in human, mouse, rat background.

HY-P86766

	*AGL/Alpha-glucosidase* Antibody (YA6459)** 1110061O17Rik antibody; 4-1 antibody; 4-glucantransferase antibody; 6-glucosidase antibody; 9430004C13Rik antibody; 9630046L06Rik antibody; AGL antibody; AI850929 antibody; Amylo 1 6 glucosidase 4 alpha glucanotransferase antibody; Amylo-1 antibody; 1110061O17Rik antibody; 4-1 antibody; 4-glucantransferase antibody; 6-glucosidase antibody; 9430004C13Rik antibody; 9630046L06Rik antibody; AGL antibody; AI850929 antibody; Amylo 1 6 glucosidase 4 alpha glucanotransferase antibody; Amylo-1 antibody; Amylo-alpha-1 antibody; C77197 antibody; Dextrin 6-alpha-D-glucosidase antibody; GDE antibody; GDE_HUMAN antibody; Glycogen debrancher antibody; Glycogen debranching enzyme antibody; Glycogen storage disease type III antibody; Oligo-1 antibody	WB, IHC-P	Human, Mouse, Rat